BioMarin Pharmaceutical Inc.

LSE:0HNC Stock Report

Market Cap: US$13.4b

BioMarin Pharmaceutical Inc. Company Information

BioMarin Pharmaceutical Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: BioMarin Pharmaceutical Inc.
  • Ticker: 0HNC
  • Exchange: LSE
  • Founded: 1996
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$13.372b
  • Shares Outstanding: 190.38m
  • Website: https://www.biomarin.com

Number of Employees


Location

  • BioMarin Pharmaceutical Inc.
  • 770 Lindaro Street
  • San Rafael
  • California
  • 94901
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BMRNNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDJul 1999
BM8DB (Deutsche Boerse AG)YesCommon StockDEEURJul 1999
BMRNWBAG (Wiener Boerse AG)YesCommon StockATEURJul 1999
0HNCLSE (London Stock Exchange)YesCommon StockGBUSDJul 1999
4BMRNETLX (Eurotlx)YesCommon StockITEURJul 1999
BMRN *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNJul 1999
B1MR34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 2 REPR 1 COMBRBRLJan 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/09/27 19:39
End of Day Share Price 2024/09/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.